...
首页> 外文期刊>Frontiers in Chemistry >Vienna LiverTox Workspace—A Set of Machine Learning Models for Prediction of Interactions Profiles of Small Molecules With Transporters Relevant for Regulatory Agencies
【24h】

Vienna LiverTox Workspace—A Set of Machine Learning Models for Prediction of Interactions Profiles of Small Molecules With Transporters Relevant for Regulatory Agencies

机译:维也纳Livertox工作空间 - 一组机器学习模型,用于预测与监管机构相关的运输工具的小分子相互作用曲线

获取原文
           

摘要

Transporters expressed in the liver play a major role in drug pharmacokinetics and are a key component of the physiological bile flow. Inhibition of these transporters may lead to drug-drug interactions or even drug-induced liver injury. Therefore, predicting the interaction profile of small molecules with transporters expressed in the liver may help medicinal chemists and toxicologists to prioritize compounds in an early phase of the drug development process. Based on a comprehensive analysis of the data available in the public domain, we developed a set of classification models which allow to predict - for a small molecule - the inhibition of and transport by a set of liver transporters considered to be relevant by FDA, EMA, and the Japanese regulatory agency. The models were validated by cross-validation and external test sets and comprise cross validated balanced accuracies in the range of 0.64 – 0.88. Finally, models were implemented as an easy to use web-service which is freely available at https://livertox.univie.ac.at.
机译:在肝脏中表达的转运蛋白在药物药代动力学中发挥着重要作用,是生理胆汁流动的关键组成部分。抑制这些转运蛋白可能导致药物 - 药物相互作用甚至药物诱导的肝损伤。因此,预测肝脏中表达的转运蛋白的小分子的相互作用谱可以有助于药用化学药剂和毒理学家在药物发育过程的早期阶段优先考虑化合物。基于对公共领域可用数据的全面分析,我们开发了一系列分类模型,允许预测 - 对于小分子 - 通过FDA,EMA相关的一组肝脏转运蛋白的抑制和运输和日本监管机构。通过交叉验证和外部测试组验证模型,并包括交叉验证的平衡精度,范围为0.64-0.88。最后,模型被实现为易于使用的网络服务,它在https://livertox.univie.ac.at上自由使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号